...

Kenji Tanaka, MD, PhD

Kenji Tanaka, MD, PhD

Division of Brain Sciences
Institute for Advanced Medical Research
Keio University School of Medicine
35 Shinanomachi, Shinjuku
Tokyo 160-8582
Japan
T: +81-3-5363-3934
E: kftanaka@keio.jp
W: http://www.psy-keiomed-ect.com

Kenji Tanaka, full professor in Neurochemistry, is working at Institute for Advanced Medical Research, Keio University School of Medicine in Japan. He has been conducting glial cell research for more than 20 years and has been working on several leukodystrophy mouse models since 2003. In the field of MLC research, he independently generated Mlc1 knockout mice and demonstrated that either loss or gain of function of the Mlc1 gene caused leukoencephalopathy in mice. He is an expert in cell type-specific and time-controllable gene expression technique and has extensive experiences in the modern circuit genetics as well. Currently, he is spearheading efforts to initiate clinical trials in Japan for MLC gene therapy using recombinant AAV vectors, with preclinical AAV efficacy studies underway.

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.